978-3-030-92612-0.pdf

This open access book reflects on matters of social and ethical concern raised in the daily practices of those working in and around precision oncology. Each chapter addresses the experiences, concerns and issues at stake for people who work in settings where precision oncology is practiced, enacted...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Γλώσσα:English
Έκδοση: Springer Nature 2022
Διαθέσιμο Online:https://link.springer.com/978-3-030-92612-0
id oapen-20.500.12657-54019
record_format dspace
spelling oapen-20.500.12657-540192022-04-14T03:01:34Z Precision Oncology and Cancer Biomarkers Bremer, Anne Strand, Roger cancer biomarkers Sociology of medicine Science and Technology Studies Oncology Philosophy of medicine precision oncology personalised cancer treatments health technology assessment Open access bic Book Industry Communication::H Humanities::HP Philosophy bic Book Industry Communication::P Mathematics & science::PS Biology, life sciences::PSA Life sciences: general issues::PSAD Bio-ethics bic Book Industry Communication::M Medicine::MJ Clinical & internal medicine::MJC Diseases & disorders::MJCL Oncology bic Book Industry Communication::M Medicine::MB Medicine: general issues::MBN Public health & preventive medicine bic Book Industry Communication::K Economics, finance, business & management::KC Economics::KCQ Health economics This open access book reflects on matters of social and ethical concern raised in the daily practices of those working in and around precision oncology. Each chapter addresses the experiences, concerns and issues at stake for people who work in settings where precision oncology is practiced, enacted, imagined or discussed. It subsequently discusses and analyses bioethical dilemmas, scientific challenges and economic trade-offs, the need for new policies, further technological innovation, social work, as well as phenomenological research. This volume takes a broad actor-centred perspective as, whenever cancer is present, the range of actors with issues at stake appears almost unlimited. This perspective and approach opens up the possibility for further in-depth and diverse questions, posed by the actors themselves, such as: How are cancer researchers navigating biological uncertainties? How do clinicians and policy-makers address ethical dilemmas around prioritisation of care? What are the patients’ experiences with, and hopes for, precision oncology? How do policy-makers and entrepreneurs envisage precision oncology? These questions are of great interest to a broad audience, including cancer researchers, oncologists, policy-makers, medical ethicists and philosophers, social scientists, patients and health economists. 2022-04-13T15:08:50Z 2022-04-13T15:08:50Z 2022 book ONIX_20220413_9783030926120_14 9783030926120 https://library.oapen.org/handle/20.500.12657/54019 eng Human Perspectives in Health Sciences and Technology application/pdf n/a 978-3-030-92612-0.pdf https://link.springer.com/978-3-030-92612-0 Springer Nature Springer International Publishing 10.1007/978-3-030-92612-0 10.1007/978-3-030-92612-0 6c6992af-b843-4f46-859c-f6e9998e40d5 9783030926120 Springer International Publishing 5 281 Cham open access
institution OAPEN
collection DSpace
language English
description This open access book reflects on matters of social and ethical concern raised in the daily practices of those working in and around precision oncology. Each chapter addresses the experiences, concerns and issues at stake for people who work in settings where precision oncology is practiced, enacted, imagined or discussed. It subsequently discusses and analyses bioethical dilemmas, scientific challenges and economic trade-offs, the need for new policies, further technological innovation, social work, as well as phenomenological research. This volume takes a broad actor-centred perspective as, whenever cancer is present, the range of actors with issues at stake appears almost unlimited. This perspective and approach opens up the possibility for further in-depth and diverse questions, posed by the actors themselves, such as: How are cancer researchers navigating biological uncertainties? How do clinicians and policy-makers address ethical dilemmas around prioritisation of care? What are the patients’ experiences with, and hopes for, precision oncology? How do policy-makers and entrepreneurs envisage precision oncology? These questions are of great interest to a broad audience, including cancer researchers, oncologists, policy-makers, medical ethicists and philosophers, social scientists, patients and health economists.
title 978-3-030-92612-0.pdf
spellingShingle 978-3-030-92612-0.pdf
title_short 978-3-030-92612-0.pdf
title_full 978-3-030-92612-0.pdf
title_fullStr 978-3-030-92612-0.pdf
title_full_unstemmed 978-3-030-92612-0.pdf
title_sort 978-3-030-92612-0.pdf
publisher Springer Nature
publishDate 2022
url https://link.springer.com/978-3-030-92612-0
_version_ 1771297487532851200